Eikon Therapeutics, Inc. (EIKN) Institutional Shareholders
Eikon Therapeutics, Inc. (EIKN) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $339.44M in EIKN holdings during the latest filing period.
Fmr Llc is currently the largest disclosed institutional shareholder of EIKN tracked by InsiderSet, reporting ownership valued at approximately $65.17M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $44.70M, representing an estimated loss of -31.42% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 75% of the total disclosed EIKN value among the investors covered in this analysis. Major shareholders include Fmr Llc, Blackrock, Inc., Foresite Capital Management Iv, Llc, and several other long-term asset managers with concentrated positions in Eikon Therapeutics, Inc. (EIKN).
This page ranks the largest institutional EIKN shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
75
Total Reported Value
$339.44M
Largest Holder
Fmr Llc
Largest Position
$65.17M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
87
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Fmr Llc | 0.00% | 4,993,906 | $65,170,473 | $44,695,459 | -$20,475,014 | -31.42% | |
| Blackrock, Inc. | 0.00% | 4,281,425 | $55,872,596 | $38,318,754 | -$17,553,842 | -31.42% | |
| Foresite Capital Management Iv, Llc | 8.74% | 1,943,682 | $25,365,050 | $17,395,954 | -$7,969,096 | -31.42% | |
| Merck & Co., Inc. | 4.13% | 1,666,666 | $21,749,991 | $14,916,661 | -$6,833,330 | -31.42% | |
| T. Rowe Price Investment Management, Inc. | 0.01% | 1,595,274 | $20,819,000 | $14,277,702 | -$6,541,298 | -31.42% | |
| Foresite Capital Management V, Llc | 4.75% | 1,318,983 | $17,212,728 | $11,804,898 | -$5,407,830 | -31.42% | |
| Capital World Investors | 0.00% | 1,175,944 | $15,346,069 | $10,524,699 | -$4,821,370 | -31.42% | |
| Price T Rowe Associates Inc | 0.00% | 1,005,035 | $13,117,000 | $8,995,063 | -$4,121,937 | -31.42% | |
| Vanguard Capital Management Llc | 0.00% | 922,707 | $12,041,326 | $8,258,228 | -$3,783,098 | -31.42% | |
| Ecor1 Capital, Llc | 0.47% | 732,606 | $9,560,508 | $6,556,824 | -$3,003,684 | -31.42% | |
| Geode Capital Management, Llc | 0.00% | 556,955 | $7,270,592 | $4,984,747 | -$2,285,845 | -31.44% | |
| Baker Bros. Advisors Lp | 0.04% | 555,555 | $7,249,993 | $4,972,217 | -$2,277,776 | -31.42% | |
| Alliancebernstein L.P. | 0.00% | 641,888 | $6,791,175 | $5,744,898 | -$1,046,277 | -15.41% | |
| Soros Capital Management Llc | 1.13% | 484,672 | $6,324,969 | $4,337,814 | -$1,987,155 | -31.42% | |
| Stepstone Group Lp | 0.24% | 395,340 | $5,159,187 | $3,538,293 | -$1,620,894 | -31.42% | |
| Canada Pension Plan Investment Board | 0.00% | 379,024 | $4,946,263 | $3,392,265 | -$1,553,998 | -31.42% | |
| State Street Corp | 0.00% | 354,093 | $4,620,914 | $3,169,132 | -$1,451,782 | -31.42% | |
| General Catalyst Group Management, Llc | 2.11% | 305,233 | $3,983,291 | $2,731,835 | -$1,251,456 | -31.42% | |
| Ubs Group Ag | 0.00% | 263,932 | $3,444,313 | $2,362,191 | -$1,082,122 | -31.42% | |
| Parkman Healthcare Partners Llc | 0.34% | 256,053 | $3,341,492 | $2,291,674 | -$1,049,818 | -31.42% | |
| Charles Schwab Investment Management Inc | 0.00% | 182,105 | $2,376,470 | $1,629,840 | -$746,630 | -31.42% | |
| Schonfeld Strategic Advisors Llc | 0.01% | 179,775 | $2,346,063 | $1,608,986 | -$737,077 | -31.42% | |
| Northern Trust Corp | 0.00% | 175,927 | $2,295,847 | $1,574,547 | -$721,300 | -31.42% | |
| Ensign Peak Advisors, Inc | 0.00% | 200,000 | $2,116,000 | $1,790,000 | -$326,000 | -15.41% | |
| Vanguard Portfolio Management Llc | 0.00% | 148,895 | $1,943,080 | $1,332,610 | -$610,470 | -31.42% | |
| Vanguard Fiduciary Trust Co | 0.00% | 148,410 | $1,936,751 | $1,328,270 | -$608,482 | -31.42% | |
| Bnp Paribas Asset Management Holding S.A. | 0.00% | 134,498 | $1,755,199 | $1,203,757 | -$551,442 | -31.42% | |
| Millennium Management Llc | 0.00% | 133,020 | $1,735,911 | $1,190,529 | -$545,382 | -31.42% | |
| Comprehensive Financial Management Llc | 0.05% | 116,276 | $1,517,402 | $1,040,670 | -$476,732 | -31.42% | |
| Burkehill Global Management, Lp | 0.05% | 115,000 | $1,500,750 | $1,029,250 | -$471,500 | -31.42% | |
| Affinity Asset Advisors, Llc | 0.06% | 98,001 | $1,278,913 | $877,109 | -$401,804 | -31.42% | |
| Td Asset Management Inc | 0.00% | 57,074 | $744,816 | $510,812 | -$234,004 | -31.42% | |
| Alps Advisors Inc | 0.00% | 54,948 | $717,071 | $491,785 | -$225,286 | -31.42% | |
| Invesco Ltd. | 0.00% | 50,900 | $664,245 | $455,555 | -$208,690 | -31.42% | |
| Bank Of New York Mellon Corp | 0.00% | 47,788 | $623,634 | $427,703 | -$195,931 | -31.42% | |
| Tcg Crossover Management, Llc | 0.01% | 37,902 | $494,621 | $339,223 | -$155,398 | -31.42% | |
| Bank Of America Corp | 0.00% | 37,575 | $490,354 | $336,296 | -$154,058 | -31.42% | |
| Polen Capital Management | David M. Polen | 0.00% | 35,742 | $466,433 | $319,891 | -$146,542 | -31.42% |
| Manufacturers Life Insurance Company, The | 0.00% | 35,357 | $461,409 | $316,445 | -$144,964 | -31.42% | |
| Proshare Advisors Llc | 0.00% | 29,685 | $387,389 | $265,681 | -$121,708 | -31.42% | |
| Nuveen, Llc | 0.00% | 28,988 | $378,293 | $259,443 | -$118,850 | -31.42% | |
| Xtx Topco Ltd | 0.00% | 27,455 | $358,288 | $245,722 | -$112,566 | -31.42% | |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 26,797 | $349,701 | $239,833 | -$109,868 | -31.42% |
| Rhumbline Advisers | 0.00% | 24,483 | $319,496 | $219,123 | -$100,373 | -31.42% | |
| Deutsche Bank Ag\ | 0.00% | 21,522 | $280,862 | $192,622 | -$88,240 | -31.42% | |
| Wells Fargo & Company/Mn | 0.00% | 19,348 | $252,491 | $173,165 | -$79,326 | -31.42% | |
| Jump Financial, Llc | 0.00% | 18,069 | $235,800 | $161,718 | -$74,082 | -31.42% | |
| Citigroup Inc | 0.00% | 16,779 | $218,966 | $150,172 | -$68,794 | -31.42% | |
| Tudor Investment Corp Et Al | 0.00% | 15,000 | $195,750 | $134,250 | -$61,500 | -31.42% | |
| Metlife Investment Management, Llc | 0.00% | 13,755 | $179,503 | $123,107 | -$56,396 | -31.42% |
Frequently asked questions about EIKN
Who owns the most EIKN stock?
The largest holders of EIKN are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for Eikon Therapeutics, Inc. (EIKN).
Is EIKN widely held by superinvestors?
Many widely followed stocks like EIKN appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly EIKN is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.